Jang S-H, Chea J-W, Lee K-B
Division of Nephrology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Nephrol. 2010 Mar;73(3):204-9. doi: 10.5414/cnp73204.
Mortality risks in ESRD (end stage renal disease) patients are related to comorbid diseases. The Charlson Comorbidity Index (CCI) has been reported to be a strong predictor of survival in incipient ESRD patients. The authors studied the validity of CCI using administrative database according to International Classification of Disease, 10th revision (ICD-10) codes, to devise a more straightforward method of determining CCI than that based on medical records review.
Incident peritoneal dialysis patients (N = 134) were enrolled from 1997 through 2007. We compared CCI scored by the administrative database (A-CCI) with CCI scored by medical records review (R-CCI). These CCI scores and patients' outcomes were analyzed.
For all patients, mean A-CCI and R-CCI were 5.3 +/- 2.1 (range 2 - 11) and 5.4 +/- 2.1 (range 2 - 11), respectively. High correlation was found between A-CCI and R-CCI scores (r = 0.88, p < 0.01). The sensitivity of A-CCI was high (0.57 - 1.00) for nine comorbidities, but sensitivities for chronic pulmonary disease and peptic ulcer disease were poor (< 0.50). However, specificity was excellent for most comorbidities. Three comorbidity groups were established by tertile ranking: low comorbidity (score = 2 - 4), moderate comorbidity (score = 5 - 6), and high comorbidity (score = 7-11). The mortality rates were; 7.17, 15.96, and 23.07/100 patient-years by A-CCI, and 6.69, 13.58 and 28.16/100 patient-years by R-CCI, respectively.
CCI scores from administrative database using ICD-10 were similar to CCI scores by medical records review. This method is simple and valid to predict the outcomes of incipient PD patients.
终末期肾病(ESRD)患者的死亡风险与合并症相关。据报道,Charlson合并症指数(CCI)是早期ESRD患者生存的有力预测指标。作者使用根据国际疾病分类第10版(ICD - 10)编码的行政数据库研究了CCI的有效性,以设计一种比基于病历审查更直接的确定CCI的方法。
1997年至2007年纳入新发病例的腹膜透析患者(N = 134)。我们将行政数据库评分的CCI(A - CCI)与病历审查评分的CCI(R - CCI)进行比较。对这些CCI评分和患者结局进行分析。
所有患者的平均A - CCI和R - CCI分别为5.3±2.1(范围2 - 11)和5.4±2.1(范围2 - 11)。A - CCI和R - CCI评分之间发现高度相关性(r = 0.88,p < 0.01)。A - CCI对9种合并症的敏感性较高(0.57 - 1.00),但对慢性肺病和消化性溃疡病的敏感性较差(< 0.50)。然而,大多数合并症的特异性良好。通过三分位数排名建立了三个合并症组:低合并症(评分 = 2 - 4)、中度合并症(评分 = 5 - 6)和高合并症(评分 = 7 - 11)。A - CCI的死亡率分别为7.17、15.96和23.07/100患者年,R - CCI的死亡率分别为6.69、13.58和28.16/100患者年。
使用ICD - 10的行政数据库的CCI评分与病历审查的CCI评分相似。这种方法简单且有效地预测早期腹膜透析患者的结局。